详情页 - 聚合机构库演示平台

当前位置：首页 > 详情页

A Promising Result of Two Therapeutic Peptides Combined with Chemotherapy in the Treatment of Advanced NSCLC

文献详情

资源类型：

WOS体系：

收录情况： ◇ SCIE

作者：

单位： [1]Wuhan Cell Marker & Machine Co Ltd, Wuhan, Peoples R China [2]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Wuhan, Peoples R China [3]Kangde Hlth Hosp Dongying, Dongying, Peoples R China

出处：

ISSN：

关键词： advanced NSCLC therapeutic peptides chemotherapy

语种：

WOS：

中科院(CAS)分区：

出版当年[2020]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学 1 区呼吸系统

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学 1 区呼吸系统

JCR分区：

出版当年[2019]版：

Q1 RESPIRATORY SYSTEM Q1 ONCOLOGY

最新[2023]版：

Q1 ONCOLOGY Q1 RESPIRATORY SYSTEM

影响因子： 21.1 最新[2023版] 16.5 最新五年平均 13.357 出版当年[2019版] 10.089 出版当年五年平均 12.46 出版前一年[2018版] 15.609 出版后一年[2020版]

第一作者：

第一作者单位： [1]Wuhan Cell Marker & Machine Co Ltd, Wuhan, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Efficacy and Biomarker Analysis of Camrelizumab in Combination with Apatinib in Patients with Advanced Nonsquamous NSCLC Previously Treated with Chemotherapy [2]Efficacy and biomarker analysis of camrelizumab in combination with apatinib in patients with advanced non-squamous NSCLC previously treated with chemotherapy. [3]Salvage surgery following downstaging of advanced non-small cell lung cancer by targeted therapy [4]Amivantamab vs Real World Therapies for Advanced NSCLC with EGFR Exon20ins in China [5]利肺健脾方辅助治疗对晚期NSCLC患者炎症因子、肿瘤标志物的影响 [6]Tepotinib With Gefitinib in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) [7]Evaluation of the Efficacy of Salvage Surgery for Advanced NSCLC Patients After Neoadjuvant Therapy by Gefitinib [8]Dynamic mutation profiles of Chinese patients with EGFR T790M advanced NSCLC receiving osimertinib [9]Real-world treatment patterns and clinical outcomes in EGFR-mutant unresectable locally advanced NSCLC (LA-NSCLC): A retrospective multicenter study of 367 patients. [10]盐酸埃克替尼治疗190例晚期非小细胞肺癌疗效及不良反应